A61K 35/54
Ovaries
Official title: Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
A61K35/54 (Ovaries) appears on 785 US grants and 1,829 published applications in this corpus.
Search patents in A61K- Granted patents
- 785
- Published applications
- 1,829
- Assignees
- 780
- Inventors
- 3,159
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 3 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 4 | 0 |
| 1998 | 5 | 0 |
| 1999 | 2 | 0 |
| 2000 | 2 | 0 |
| 2001 | 5 | 0 |
| 2002 | 0 | 13 |
| 2003 | 5 | 12 |
| 2004 | 0 | 15 |
| 2005 | 3 | 23 |
| 2006 | 2 | 22 |
| 2007 | 5 | 35 |
| 2008 | 9 | 21 |
| 2009 | 9 | 33 |
| 2010 | 12 | 36 |
| 2011 | 9 | 42 |
| 2012 | 18 | 59 |
| 2013 | 20 | 60 |
| 2014 | 43 | 76 |
| 2015 | 39 | 95 |
| 2016 | 46 | 119 |
| 2017 | 51 | 99 |
| 2018 | 49 | 111 |
| 2019 | 55 | 116 |
| 2020 | 43 | 120 |
| 2021 | 58 | 140 |
| 2022 | 57 | 148 |
| 2023 | 51 | 135 |
| 2024 | 53 | 120 |
| 2025 | 73 | 101 |
| 2026 | 43 | 78 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Extracellular vesicles from stem cells to treat and/or prevent disease1 Sep 2026US 12,721,867 B2Children’s Hospital Los Angeles
- Modulation of splenocytes in cell therapy1 Sep 2026US RE51,018 E1Board of Regents, The University of Texas System
- Diagnostic and drug screening for molecular signatures of early onset sporadic parkinson's disease18 Aug 2026US 12,708,611 B2Cedars-Sinai Medical Center
- Mechanical and biochemical activation and control of skeletal stem cells for cartilage regeneration28 Jul 2026US 12,691,161 B2The Board of Trustees of the Leland Stanford Junior University
- Variant ICOS ligand immunomodulatory proteins and related compositions and methods28 Jul 2026US 12,692,299 B2Alpine Immune Sciences, Inc.
- Methods of preventing on-target genotoxicity induced by nucleases8 Oct 2026US 2026/0306552 A1Chu De Bordeaux
- Cryopreserved endocrine cells that express chromogranin a1 Oct 2026US 2026/0294981 A1ViaCyte, Inc.
- Mechanical and biochemical activation and control of skeletal stem cells for cartilage regeneration1 Oct 2026US 2026/0295008 A1
- Ribosomal Remodeling in Diabetes1 Oct 2026US 2026/0295074 A1Joslin Diabetes Center, Inc.
- Cell1 Oct 2026US 2026/0297622 A1Antion Biosciences SA
Most cited
By later US patents
- Repair of cartilage and bones372US 4,642,120 ARamot University Authority for Applied Research and Industrial Development Ltd. · 1987
- Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood229US 5,004,681 ABiocyte Corporation · 1991
- Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells185US 7,311,905 B2Anthrogenesis Corporation · 2007
- Redirection of cellular immunity by receptor chimeras135US 7,049,136 B2The General Hospital Corporation · 2006
- Targeted cytolysis of HIV-infected cells by chimeric CD4 receptor-bearing cells108US 5,851,828 AThe General Hospital Corporation · 1998